DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's laboratories Limited
02 1Ajinomoto OmniChem N.V.
03 1Ajinomoto Omnichem
04 1Alembic Pharmaceuticals Limited
05 1Aurobindo Pharma Limited
06 2Dasami Lab Private Limited
07 1Indoco Remedies Limited
08 2Janssen Pharmaceutica NV
09 1LAURUS LABS LIMITED
10 2MSN Life Sciences Private Limited
11 1Qingdao Biopeptek Co., Ltd.
01 2CANAGLIFLOZIN
02 8Canagliflozin
03 1Canagliflozin (Amorphous)
04 1Canagliflozin (Hemihydrate)
05 1Canagliflozin Hemihydrate
06 1Not Applicable
01 1Belgium
02 9India
03 1Japan
04 3U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-978
Start Marketing Date : 2016-09-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50923-0119
Start Marketing Date : 2018-11-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50923-1216
Start Marketing Date : 2017-01-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46708-886
Start Marketing Date : 2016-10-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-065
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14445-017
Start Marketing Date : 2016-10-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12578-611
Start Marketing Date : 2013-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12578-615
Start Marketing Date : 2013-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-735
Start Marketing Date : 2017-01-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69766-002
Start Marketing Date : 2015-07-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Invokana manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Invokana, including repackagers and relabelers. The FDA regulates Invokana manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Invokana API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Invokana manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Invokana supplier is an individual or a company that provides Invokana active pharmaceutical ingredient (API) or Invokana finished formulations upon request. The Invokana suppliers may include Invokana API manufacturers, exporters, distributors and traders.
click here to find a list of Invokana suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Invokana as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Invokana API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Invokana as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Invokana and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Invokana NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Invokana suppliers with NDC on PharmaCompass.
We have 11 companies offering Invokana
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
